Clinical Molecular Diagnosis of Wilson Disease

ABSTRACT

Wilson disease is an autosomal recessive disorder of copper transport characterized by toxic accumulation of copper in the liver, brain, and other organs. It is lethal if untreated, but effective treatment is available. The broad spectrum of clinical manifestations, including hepatic and neuropsychiatric symptoms, can present over a large age range, contributing to difficulty in recognition of this disease. The diagnosis has traditionally rested on measurements of ceruloplasmin and copper in urine and liver, but it remains a challenge due to ambiguous biochemical results that can overlap with healthy carriers. Although hepatic copper concentration has been the gold standard for diagnosis, direct sequencing of the ATP7B gene is sensitive, specific, and can obviate the need for invasive liver biopsy. In this article, the authors review the sensitivity, limitations, and pitfalls of ATP7B sequencing in the diagnosis of Wilson disease. ATP7B sequencing should be standard practice in the diagnosis of Wilson disease.

KEYWORDS

Wilson disease - genetic testing - molecular diagnosis - mutation spectrum - sensitivity

REFERENCES

• 1 Wilson S AK. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver.  Brain. 1912;  34 295-507
• 2 Walshe J M. Penicillamine, a new oral therapy for Wilson's disease.  Am J Med. 1956;  21 (4) 487-495
• 3 Bull P C, Thomas G R, Rommens J M, Forbes J R, Cox D W. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene.  Nat Genet. 1993;  5 (4) 327-337
• 4 Petrukhin K, Fischer S G, Pirastu M et al.. Mapping, cloning and genetic characterization of the region containing the Wilson disease gene.  Nat Genet. 1993;  5 (4) 338-343
• 5 Tanzi R E, Petrukhin K, Chernov I et al.. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene.  Nat Genet. 1993;  5 (4) 344-350
• 6 Yamaguchi Y, Heiny M E, Gitlin J D. Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease.  Biochem Biophys Res Commun. 1993;  197 (1) 271-277
• 7 Petrukhin K, Lutsenko S, Chernov I, Ross B M, Kaplan J H, Gilliam T C. Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structure/function predictions.  Hum Mol Genet. 1994;  3 (9) 1647-1656
• 8 Sato M, Gitlin J D. Mechanisms of copper incorporation during the biosynthesis of human ceruloplasmin.  J Biol Chem. 1991;  266 (8) 5128-5134
• 9 Brewer G J, Yuzbasiyan-Gurkan V. Wilson's disease: an update, with emphasis on new approaches to treatment.  Dig Dis. 1989;  7 (4) 178-193
• 10 Scheinberg I H, Gitlin D. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease).  Science. 1952;  116 (3018) 484-485
• 11 Steindl P, Ferenci P, Dienes H P et al.. Wilson's disease in patients presenting with liver disease: a diagnostic challenge.  Gastroenterology. 1997;  113 (1) 212-218
• 12 Nicastro E, Ranucci G, Vajro P, Vegnente A, Iorio R. Re-evaluation of the diagnostic criteria for Wilson disease in children with mild liver disease.  Hepatology. 2010;  52 (6) 1948-1956
• 13 Ferenci P, Caca K, Loudianos G et al.. Diagnosis and phenotypic classification of Wilson disease.  Liver Int. 2003;  23 (3) 139-142
• 14 Ferenci P, Steindl-Munda P, Vogel W et al.. Diagnostic value of quantitative hepatic copper determination in patients with Wilson's Disease.  Clin Gastroenterol Hepatol. 2005;  3 (8) 811-818
• 15 Vrabelova S, Letocha O, Borsky M, Kozak L. Mutation analysis of the ATP7B gene and genotype/phenotype correlation in 227 patients with Wilson disease.  Mol Genet Metab. 2005;  86 (1–2) 277-285
• 16 Strom C M, Huang D, Chen C et al.. Extensive sequencing of the cystic fibrosis transmembrane regulator gene: assay validation and unexpected benefits of developing a comprehensive test.  Genet Med. 2003;  5 (1) 9-14
• 17 Messiaen L M, Callens T, Mortier G et al.. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects.  Hum Mutat. 2000;  15 (6) 541-555
• 18 Schmidt H H. Role of genotyping in Wilson's disease.  J Hepatol. 2009;  50 (3) 449-452
• 19 Nicastro E, Loudianos G, Zancan L et al.. Genotype-phenotype correlation in Italian children with Wilson's disease.  J Hepatol. 2009;  50 (3) 555-561
• 20 Butler P, McIntyre N, Mistry P K. Molecular diagnosis of Wilson disease.  Mol Genet Metab. 2001;  72 (3) 223-230
• 21 Curtis D, Durkie M, Balac (Morris) P et al.. A study of Wilson disease mutations in Britain.  Hum Mutat. 1999;  14 (4) 304-311
• 22 Thomas G R, Forbes J R, Roberts E A, Walshe J M, Cox D W. The Wilson disease gene: spectrum of mutations and their consequences.  Nat Genet. 1995;  9 (2) 210-217
• 23 Chuang L M, Wu H P, Jang M H et al.. High frequency of two mutations in codon 778 in exon 8 of the ATP7B gene in Taiwanese families with Wilson disease.  J Med Genet. 1996;  33 (6) 521-523
• 24 Nanji M S, Nguyen V T, Kawasoe J H et al.. Haplotype and mutation analysis in Japanese patients with Wilson disease.  Am J Hum Genet. 1997;  60 (6) 1423-1429
• 25 Kim E K, Yoo O J, Song K Y et al.. Identification of three novel mutations and a high frequency of the Arg778Leu mutation in Korean patients with Wilson disease.  Hum Mutat. 1998;  11 (4) 275-278
• 26 Gupta A, Aikath D, Neogi R et al.. Molecular pathogenesis of Wilson disease: haplotype analysis, detection of prevalent mutations and genotype-phenotype correlation in Indian patients.  Hum Genet. 2005;  118 (1) 49-57
• 27 Kenney S M, Cox D W. Sequence variation database for the Wilson disease copper transporter, ATP7B.  Hum Mutat. 2007;  28 (12) 1171-1177
• 28 Zappu A, Magli O, Lepori M B et al.. High incidence and allelic homogeneity of Wilson disease in 2 isolated populations: a prerequisite for efficient disease prevention programs.  J Pediatr Gastroenterol Nutr. 2008;  47 (3) 334-338
• 29 Loudianos G, Dessi V, Lovicu M et al.. Molecular characterization of Wilson disease in the Sardinian population—evidence of a founder effect.  Hum Mutat. 1999;  14 (4) 294-303
• 30 Dedoussis G V, Genschel J, Sialvera T E et al.. Wilson disease: high prevalence in a mountainous area of Crete.  Ann Hum Genet. 2005;  69 (Pt 3) 268-274
• 31 Loudianos G, Lovicu M, Solinas P et al.. Delineation of the spectrum of Wilson disease mutations in the Greek population and the identification of six novel mutations.  Genet Test. 2000;  4 (4) 399-402
• 32 García-Villarreal L, Daniels S, Shaw S H et al.. High prevalence of the very rare Wilson disease gene mutation Leu708Pro in the Island of Gran Canaria (Canary Islands, Spain): a genetic and clinical study.  Hepatology. 2000;  32 (6) 1329-1336
• 33 Møller L B, Ott P, Lund C, Horn N. Homozygosity for a gross partial gene deletion of the C-terminal end of ATP7B in a Wilson patient with hepatic and no neurological manifestations.  Am J Med Genet A. 2005;  138 (4) 340-343
• 34 Kumar N, Gross Jr J B, Ahlskog J E. Myelopathy due to copper deficiency.  Neurology. 2003;  61 (2) 273-274
• 35 Manolaki N, Nikolopoulou G, Daikos G L et al.. Wilson disease in children: analysis of 57 cases.  J Pediatr Gastroenterol Nutr. 2009;  48 (1) 72-77
• 36 Leggio L, Addolorato G, Loudianos G, Abenavoli L, Gasbarrini G. Genotype-phenotype correlation of the Wilson disease ATP7B gene.  Am J Med Genet A. 2006;  140 (8) 933
• 37 Panagiotakaki E, Tzetis M, Manolaki N et al.. Genotype-phenotype correlations for a wide spectrum of mutations in the Wilson disease gene (ATP7B).  Am J Med Genet A. 2004;  131 (2) 168-173
• 38 Takeshita Y, Shimizu N, Yamaguchi Y et al.. Two families with Wilson disease in which siblings showed different phenotypes.  J Hum Genet. 2002;  47 (10) 543-547
• 39 Horslen S, Hahn S H. Genotype-phenotype correlation in Wilson disease.  J Clin Gastroenterol. 2010;  44 (6) 387-388
• 40 Loudianos G, Dessi V, Lovicu M et al.. Mutation analysis in patients of Mediterranean descent with Wilson disease: identification of 19 novel mutations.  J Med Genet. 1999;  36 (11) 833-836
• 41 Shah A B, Chernov I, Zhang H T et al.. Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-phenotype correlation, and functional analyses.  Am J Hum Genet. 1997;  61 (2) 317-328
• 42 Deguti M M, Genschel J, Cancado E L et al.. Wilson disease: novel mutations in the ATP7B gene and clinical correlation in Brazilian patients.  Hum Mutat. 2004;  23 (4) 398
• 43 Cox D W, Prat L, Walshe J M, Heathcote J, Gaffney D. Twenty-four novel mutations in Wilson disease patients of predominantly European ancestry.  Hum Mutat. 2005;  26 (3) 280
• 44 Kalinsky H, Funes A, Zeldin A et al.. Novel ATP7B mutations causing Wilson disease in several Israeli ethnic groups.  Hum Mutat. 1998;  11 (2) 145-151
• 45 Margarit E, Bach V, Gómez D et al.. Mutation analysis of Wilson disease in the Spanish population — identification of a prevalent substitution and eight novel mutations in the ATP7B gene.  Clin Genet. 2005;  68 (1) 61-68
• 46 Owada M, Suzuki K, Fukushi M, Yamauchi K, Kitagawa T. Mass screening for Wilson's disease by measuring urinary holoceruloplasmin.  J Pediatr. 2002;  140 (5) 614-616
• 47 Figus A, Angius A, Loudianos G et al.. Molecular pathology and haplotype analysis of Wilson disease in Mediterranean populations.  Am J Hum Genet. 1995;  57 (6) 1318-1324
• 48 Yamaguchi A, Matsuura A, Arashima S, Kikuchi Y, Kikuchi K. Mutations of ATP7B gene in Wilson disease in Japan: identification of nine mutations and lack of clear founder effect in a Japanese population.  Hum Mutat. 1998;  (Suppl 1) S320-S322
• 49 Tsai C H, Tsai F J, Wu J Y et al.. Mutation analysis of Wilson disease in Taiwan and description of six new mutations.  Hum Mutat. 1998;  12 (6) 370-376
• 50 Davies L P, Macintyre G, Cox D W. New mutations in the Wilson disease gene, ATP7B: implications for molecular testing.  Genet Test. 2008;  12 (1) 139-145